These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 26790878)

  • 1. PSA and beyond: alternative prostate cancer biomarkers.
    Saini S
    Cell Oncol (Dordr); 2016 Apr; 39(2):97-106. PubMed ID: 26790878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond PSA: the next generation of prostate cancer biomarkers.
    Prensner JR; Rubin MA; Wei JT; Chinnaiyan AM
    Sci Transl Med; 2012 Mar; 4(127):127rv3. PubMed ID: 22461644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging biomarkers in the detection and prognosis of prostate cancer.
    Filella X; Foj L
    Clin Chem Lab Med; 2015 Jun; 53(7):963-73. PubMed ID: 25581761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress and perspectives on prostate cancer biomarkers.
    Hatakeyama S; Yoneyama T; Tobisawa Y; Ohyama C
    Int J Clin Oncol; 2017 Apr; 22(2):214-221. PubMed ID: 27730440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.
    Bickers B; Aukim-Hastie C
    Anticancer Res; 2009 Aug; 29(8):3289-98. PubMed ID: 19661347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New biomarkers in prostate cancer.
    Crawford ED; Ventii K; Shore ND
    Oncology (Williston Park); 2014 Feb; 28(2):135-42. PubMed ID: 24701701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landmarks in prostate cancer diagnosis: the biomarkers.
    Artibani W
    BJU Int; 2012 Oct; 110 Suppl 1():8-13. PubMed ID: 23046035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for prostate cancer detection and progression: Beyond prostate-specific antigen.
    Berney DM
    Drug News Perspect; 2010 Apr; 23(3):185-94. PubMed ID: 20440420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of prostate-specific antigen in the management of advanced prostate cancer.
    Crawford ED; Bennett CL; Andriole GL; Garnick MB; Petrylak DP
    BJU Int; 2013 Sep; 112(5):548-60. PubMed ID: 23826876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate specific antigen. Current clinical application and future prospects.
    Duskova K; Vesely S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):18-26. PubMed ID: 25277491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience.
    Merola R; Tomao L; Antenucci A; Sperduti I; Sentinelli S; Masi S; Mandoj C; Orlandi G; Papalia R; Guaglianone S; Costantini M; Cusumano G; Cigliana G; Ascenzi P; Gallucci M; Conti L
    J Exp Clin Cancer Res; 2015 Feb; 34(1):15. PubMed ID: 25651917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen.
    Fradet Y
    Curr Opin Urol; 2009 May; 19(3):243-6. PubMed ID: 19325493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for early prostate cancer detection.
    Margreiter M; Stangelberger A; Valimberti E; Herwig R; Djavan B
    Minerva Urol Nefrol; 2008 Mar; 60(1):51-60. PubMed ID: 18427435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in proteomic prostate cancer biomarker discovery.
    Goo YA; Goodlett DR
    J Proteomics; 2010 Sep; 73(10):1839-50. PubMed ID: 20398807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New circulating biomarkers for prostate cancer.
    Bensalah K; Lotan Y; Karam JA; Shariat SF
    Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non- PSA serum markers for the diagnosis of PCa].
    Mengual L; Musquera M; Ciudin A; Ribal MJ
    Arch Esp Urol; 2015 Apr; 68(3):229-39. PubMed ID: 25948796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor biomarkers: PSA and beyond.
    Melichar B
    Clin Chem Lab Med; 2012 Nov; 50(11):1865-9. PubMed ID: 23072854
    [No Abstract]   [Full Text] [Related]  

  • 19. The Prostate Health Index: Its Utility in Prostate Cancer Detection.
    Lepor A; Catalona WJ; Loeb S
    Urol Clin North Am; 2016 Feb; 43(1):1-6. PubMed ID: 26614024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness.
    Ahrens MJ; Bertin PA; Vonesh EF; Meade TJ; Catalona WJ; Georganopoulou D
    Prostate; 2013 Dec; 73(16):1731-7. PubMed ID: 23934862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.